Rating History for Halozyme Therapeutics (HALO) by BMO Capital

More Stocks Rated by BMO Capital | Latest Ratings for HALO
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/3/2021 Do Kim Maintain Outperform
(N/A)		 62.00
(66.00)		  
 		   Details